Abstract
A series of new indolyl-1,3,4-oxadiazole derivatives 37 and 10, indolyl-1,2,4-triazole derivatives 14 and 15 was prepared, using 1-(4-methoxybenzyl)-1H-indole-3-carbohydrazide (2) as a key intermediate. Some of the new compounds were evaluated for their antineoplastic activity.